This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Shrimps Disease Diagnostics Market

Market Insights on Shrimps Disease Diagnostics covering sales outlook, demand forecast & up-to-date key trends

Shrimp Disease Diagnostics Market By Reagent Kits (Assay Based Kits, Rapid Testing Kits), Disease Type (WSSV (White Spot Syndrome Virus), TSV (Taura Syndrome Virus), YHV/GAV (Yellow Head/Gill Associated Virus), IHHNV (Infectious Hypodermal and Hematopoietic Virus)) End User (Fisheries, Aquaculture And Marine Laboratories) & Region - Forecast 2022-2032

Shrimps Disease Diagnostics Market Overview

The shrimp disease diagnostics market is anticipated to record a CAGR of 11.3% during the forecast period, up from US$ 174.91 Mn in 2021 to reach a valuation of US$ 567.88 Mn by 2032.

Attributes

Details

Global Shrimp Disease Diagnostics Market Value (2021)

US$ 174.91 Mn

Global Shrimp Disease Diagnostics Market Value (2032)

US$ 567.88 Mn

Global Shrimp Disease Diagnostics Market CAGR (2022-2032)

11.3%

Sales of shrimps disease diagnostics system are expected to rise due to growing demand for shrimp farming, as well as developments in disease detection molecular diagnostics techniques. In addition to this, demand for shrimp disease diagnostics system is anticipated to rise due to the overall growth in seafood demand and the development of the disease diagnostics market share.

Increasing global production of shrimps is also projected to contribute to the growth of the shrimp disease diagnostics market share.

Due to the multiple benefits, the demand for shrimp disease diagnostics system is anticipated to grow, and the idea of biosecurity application to shrimp farming would also see a significant increase in order to reduce losses in shrimp production due to disease prevalence. As a result, sales of shrimp disease diagnostics system is anticipated to rise.

Some of the key shrimp disease diagnostics market trends promoting the demand for shrimp disease diagnostics system include technological advancement in the field of aquaculture disease diagnosis.

What are the Key Drivers to the Global Shrimp Disease Diagnostics Market Share?

Growing demand for shrimps for human consumption and nutrient purpose is the major favour expected to boost up the sales of shrimp disease diagnostics system and the growth of shrimp disease diagnostics market. Rising demand for freshwater and marine shrimp farming is the major driving factor of the disease diagnostics market share.

Shrimp farming is gaining popularity for production of shrimp for human consumption. Thus, the demand for shrimp disease diagnostics system is also rising. Bacterial and viral infections are a major threat to the shrimp production industry in various countries. Shrimp production in many countries continues to face economic losses due to different diseases.

Disease problems in shrimp production are poorly understood and diagnosed. This factor propels the demand for shrimp disease diagnostics system to counter all the disease in shrimps. As a result, the sales of shrimp disease diagnostics system is also anticipated to grow during the forecast period.

Various shrimps diseases such as white spot diseases highly affect shrimp production and continue to pose a serious challenge, which is anticipated to affect the sales of shrimp disease diagnostics system.

There is no therapeutic option available for viral diseases, and the only option available is to detect and avoid the pathogen entry into culture systems. Therefore, the only option left is shrimps disease diagnostics.

This is also a major factor that is anticipated to augment the demand for shrimp disease diagnostics system and support the growth of disease diagnostics market share.

DNA based diagnostic tools such as PCR are used to test. Diagnosis tools and technologies are gaining demand for shrimp disease diagnostics system for quick and effective diagnosis of shrimp diseases to manage the disease outbreaks. Assay based kits and rapid test kits are available for the shrimp disease diagnostic market.

Customize this Report

Let us know your requirement to get
100% FREE customization

Which Region holds the Largest Global Shrimp Disease Diagnostics Market Share?

The Asia Pacific is expected to dominate the shrimp disease diagnostics market as high production rate in China and India. Sales of shrimp disease diagnostics system are increasing on the global level especially in Asia Pacific countries such as India and China. About 30% of farmed shrimp is produced in Asia, particularly in China and Indonesia.

Shrimps disease diagnostics market is expected to represent prominent growth in the countries such as the United States, Japan and Western Europe.

Growing consumption of shrimps in the food and strict regulatory policies regarding food safety in the countries such as the U.S. and Japan are expected to boost up the sales of shrimps disease diagnostics system and the growth of the shrimp disease diagnostics market.

Who are the Key Players in the Global Shrimp Disease Diagnostics Market?

Key players in global shrimps disease diagnostics market are HiMedia Laboratories, Speedy Assay Sdn Bhd, REAGEN LLC, FUJIKURA KASEI CO., LTD., GeneReach Biotechnology Corp., Thermo Fisher Scientific, Lab - Ind Resource Sdn Bhd., AquaBounty Technologies, Inc., GeneReach Biotechnology Corp., pop bio, SUREBIO, Auro Biotechnologies and others.

Recent Developments

  • In October 2020, Thermo Fisher Scientific and the Terasaki Innovation Center (TIC) signed a collaborative agreement to speed the research and development of new routes and tools for diagnosing and managing transplant patients. As a result of this agreement, Thermo Fisher will be the first to produce novel technologies developed by the TIC for use by doctors, laboratories, and transplant centres all around the world.
  • Thermo Fisher Scientific has agreed to buy PPD, a clinical research company, for $17.4 billion in April 2021, the firms said this morning, in a deal that will further concentrate contract research organisations (CROs) into a few corporate behemoths.
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Scope Of Report

Report Attribute

Details

Growth rate

CAGR of 11.3% from 2022 to 2032

Base year for estimation

2021

Historical data

2015 – 2020

Forecast period

2022 – 2032

Quantitative units

Revenue in USD billion, volume in kilotons, and CAGR from 2022 to 2032

Report coverage

Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis,

Segments covered

Reagent Kits, Disease type, End user, region

Regional scope

North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand

Country scope

U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa

Key companies profiled

HiMedia Laboratories, Speedy Assay Sdn Bhd, REAGEN LLC, FUJIKURA KASEI CO., LTD., GeneReach Biotechnology Corp., Thermo Fisher Scientific, Lab - Ind Resource Sdn Bhd., AquaBounty Technologies, Inc., GeneReach Biotechnology Corp., pop bio, SUREBIO, Auro Biotechnologies

Customization scope

Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs.

Frequently Asked Questions

The global shrimp disease diagnostics market is likely to register a CAGR of 11.3% during the forecast period.

Key players holding substantial global shrimp disease diagnostics market share include HiMedia Laboratories, Speedy Assay Sdn Bhd, REAGEN LLC, FUJIKURA KASEI CO., LTD., GeneReach Biotechnology Corp., Thermo Fisher Scientific, Lab - Ind Resource Sdn Bhd., AquaBounty Technologies, Inc., GeneReach Biotechnology Corp., pop bio, SUREBIO, Auro Biotechnologies.

As per the analysis, the global shrimp disease diagnostics market share is likely to be US$ 567.88 Mn by 2032.

Demand for shrimp disease diagnostics system is likely to rise due to growing demand for shrimp farming, as well as developments in disease detection molecular diagnostics techniques.

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Shrimps Disease Diagnostics Market